Takaaki Ohara

Title: Takaaki Ohara: Innovator in Hematology

Introduction

Takaaki Ohara is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of hematology through his innovative research and development of monoclonal antibodies and cell adhesion proteins. With a total of 2 patents, his work has the potential to impact medical diagnostics and treatments.

Latest Patents

Ohara's latest patents include a monoclonal antibody and its immunoreactive fragment, which utilize a novel HSCA-3 antigen found in immature hemopoietic stem cells. This invention is aimed at enhancing immunoassays and flow cytometry techniques, as well as isolating and purifying immature hemopoietic stem cells from various sources, including human bone marrow and umbilical cord blood. Additionally, he has developed a patent related to a sheep LFA-3 protein and its derivatives, which exhibit a high affinity for human T-cells, along with the corresponding genes and processes for their preparation.

Career Highlights

Throughout his career, Takaaki Ohara has worked with prominent companies such as Kanegafuchi Kagaku Kogyo and Kaneka Corporation. His experience in these organizations has allowed him to refine his expertise in the field of biotechnology and contribute to groundbreaking research.

Collaborations

Ohara has collaborated with esteemed colleagues, including Kenji Yamashita and Tetsu Kakutani. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Takaaki Ohara's contributions to the field of hematology through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical science and technology.